Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for ITGR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 1.719B
March 31, 2026 1.697B
December 31, 2025 1.747B
September 30, 2025 1.746B
June 30, 2025 1.704B
March 31, 2025 1.607B
December 31, 2024 1.619B
September 30, 2024 1.621B
June 30, 2024 1.554B
March 31, 2024 1.525B
December 31, 2023 1.519B
September 30, 2023 1.463B
June 30, 2023 1.446B
March 31, 2023 1.418B
December 31, 2022 1.417B
September 30, 2022 1.355B
June 30, 2022 1.363B
March 31, 2022 1.364B
December 31, 2021 1.355B
September 30, 2021 1.332B
June 30, 2021 1.315B
March 31, 2021 1.278B
December 31, 2020 1.271B
September 30, 2020 1.233B
June 30, 2020 1.181B
Date Value
March 31, 2020 1.164B
December 31, 2019 1.152B
September 30, 2019 1.129B
June 30, 2019 1.112B
March 31, 2019 1.076B
December 31, 2018 1.060B
September 30, 2018 1.039B
June 30, 2018 917.73M
March 31, 2018 920.39M
December 31, 2017 893.38M
September 30, 2017 823.43M
June 30, 2017 783.13M
March 31, 2017 740.66M
December 31, 2016 725.24M
September 30, 2016 741.02M
June 30, 2016 723.47M
March 31, 2016 732.46M
December 31, 2015 850.62M
September 30, 2015 645.86M
June 30, 2015 641.60M
March 31, 2015 628.47M
December 31, 2014 613.36M
September 30, 2014 597.06M
June 30, 2014 583.46M
March 31, 2014 566.82M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 4.769B
Integra LifeSciences Holdings Corp. 1.043B
Abbott Laboratories 51.11B
AngioDynamics, Inc. 170.82M
Alphatec Holdings, Inc. 11.53M

Shareholders Equity (Quarterly) Related Metrics